Covid-19 in Ocrelizumab-treated people with Multiple Sclerosis

This article, written by the Journal of Multiple Sclerosis and related disorders,  (MSARD) includes data from clinical trials, post marketing safety surveillance and a US electronic medical records database, Optum. The objective was to better understand the SARS-CoV-2 infection in ocrelizumab-treated people with MS. The results show: Roche/Genentech clinical trial data: There were 51 (1.3%) […]

Bid now on stunning handcrafted items and support better MS treatment access.

👉 Bid on Trade Me

🧡 Auction ends Sunday!

About Multiple Sclerosis

MS Brain Health

MS Stories

Want to shape the future of MS Care in New Zealand?
Your Health Team: An Introduction to Community Advisors
DSS Update: Improvements to Assessment, Allocation & Flexible Funding

Living with MS

Managing MS

Treating MS

Multiple Sclerosis NZ